Amwill Healthcare IPO Details
The Amwill Healthcare IPO is a book build issue with a total issue size of ₹59.98 cr, comprising of fresh issue of 4403600 equity shares., and a offer for sale of 1000000 equity shares. Amwill Healthcare IPO opened for subscription on Feb 05, 2025 and closed on Feb 07, 2025. Amwill Healthcare IPO is set price band at ₹105 to ₹111 per share, with a lot size of 1200 shares. Minimum investment for Retail investors was ₹266,400.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Feb 10, 2025, and listed on both the NSE and BSE on Feb 12, 2025.
Bigshare Services Pvt Ltd has been appointed as the registrar. Unistone Capital Pvt Ltd are the Book Running Lead Manager for the issue.
Before investing in the Amwill Healthcare IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 105 – 111
- Lot Size
- 1200
- Issue Size
- ₹59.98 Cr
- Minimum Investment
- ₹266400 (2400 Shares)
- Listing Date
- 12 February 2025
Current GMP
₹11 (+9.91%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Amwill Healthcare Limited
Amwill Healthcare Limited is a derma-cosmetic development company that focuses on creating dermatological, cosmeceutical, and aesthetic products. The company partners with contract manufacturers, distributors, and third-party development agencies to handle manufacturing, packaging, and distribution, enabling it to concentrate on product formulation and development. Its operations are concentrated in Karnataka, Andhra Pradesh, and Telangana, with plans to expand to West Bengal and Odisha.
The company’s product portfolio includes generic dermatological solutions and specialized formulations addressing specific skin problems. Amwill's products are developed with input from dermatologists, and its managing director, Anand Gandhi, has played a significant role in product development. The company has developed several products, though some were discontinued due to lack of market response.
Amwill collaborates with contract manufacturers to ensure quality compliance and leverages third-party developers for active ingredient preparation. Distribution is handled by Amderma Healthcare LLP, a promoter group entity that stores and delivers Amwill’s products to customers.
The company has a structured sales and marketing team, focusing on doctor relationships, exhibitions, and scientific journals to promote its products. The management team has over 20 years of experience in the dermatology industry, providing a competitive edge for the company's growth.
Financially, Amwill has shown significant growth, with a revenue increase from ₹1,799.94 lakhs in FY2021 to ₹3,578.83 lakhs in FY2023. Its EBITDA and profit after tax have also improved, indicating strong financial performance.
Amwill Healthcare IPO Promoters
- Anand Gandhi
- Tarun Gandhi
Promoters Holding
Holding Pre Issue
97.00%
Holding Post Issue
0.00%
Amwill Healthcare IPO Objective
The company proposes to utilize the Net Proceeds in the following manner.
- Funding of working capital requirements of the Company
- Marketing and brand-building activities
- General corporate purposes
Address / Contact Info
Amwill Healthcare Limited
No. 157, 1st Floor, 2nd Main, 3rd
Cross Chamrajpet,
Bangalore – 560018, Karnataka
Phone: +91 8043026281
Email: amwill@amwillhealthcare.com
Website: https://www.amwillhealthcare.com/
IPO Snapshot
Book Running Lead Managers
- Unistone Capital Pvt Ltd
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Amwill Healthcare IPO is a Book-building IPO with a total issue size of ₹59.98 crore. The Amwill Healthcare IPO price band is ₹105 to 111 per share. The Amwill Healthcare IPO subscription opens on Wed, Feb 5, 2025, and closes on Fri, Feb 7, 2025. The Amwill Healthcare IPO will be listed on the BSE. Bigshare Services Pvt Ltd is the registrar for the Amwill Healthcare IPO.
The Amwill Healthcare IPO opens on Wed, Feb 5, 2025 and closes on Fri, Feb 7, 2025
Amwill Healthcare IPO Price Band is ₹105 to 111 per share.
Amwill Healthcare IPO lot size is 1200 shares, Retail investors need a minimum investment of ₹266400 based on the upper price band
The minimum investment for Amwill Healthcare IPO is ₹266400, based on one lot of 1200 shares at the upper price band of ₹111 per share.
Investors can apply for the Amwill Healthcare IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Fri, Feb 7, 2025. The application amount remains blocked until the Amwill Healthcare IPO allotment is finalized.
Amwill Healthcare IPO issue size is ₹59.98 crores.
Amwill Healthcare IPO allotment date is Wed, Jul 1, 2026.
The registrar for Amwill Healthcare IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website to check Amwill Healthcare IPO allotment status, refund processing, and other IPO-related information.
The Amwill Healthcare IPO GMP (Grey Market Premium) is ₹3 as of Fri, Feb 7, 2025. Based on the upper price band of ₹111 per share, the estimated Amwill Healthcare IPO listing price is ₹114, indicating a potential listing gain of approximately 0% over the issue price.